About Lakefront Biotherapeutics, Inc.
Galapagos is now Lakefront Biotherapeutics.
- Industry
- Biotechnology Research
- Company size
- 51-200 employees
- Headquarters
- Mechelen
- Company type
- Public Company
- Company profile name
- Lakefront Biotherapeutics
Lakefront Biotherapeutics (formerly known as Galapagos) is a biotechnology company built to bring meaningful medicines to patients with serious diseases in therapeutic areas of unmet need. The Company combines world-class deal making expertise with capital to identify, acquire, and advance promising opportunities that have the potential to drive value for patients and shareholders. Applying a modality-agnostic asset selection approach and operational flexibility, Lakefront Biotherapeutics prioritizes oncology and immunology & inflammation programs with clear clinical proof-of-concept in emerging areas.
Company locations
Mechelen, BE
Chicago, IL, US
San Francisco, CA, US
Locations listed on the company profile. These may include offices outside the United States, and not every location is hiring.
On LinkedIn
- People linked to this company
- 51
People who list this company on LinkedIn, not a verified employee count. Figures reflect the saved company profile.
Explore the company
Employer category
Other employer
Estimated from the company profile. This category has not been confirmed by the employer.